Key facts
- This page summarizes Matthew E. Korenberg's Form 4 filing for PALVELLA THERAPEUTICS, INC. (PVLA).
- 2 reported transactions and 1 derivative row are listed below.
- Accepted by SEC: 16 Jun 2026, 16:05.
Matthew E. Korenberg - 12 Jun 2026 Form 4 Insider Report for PALVELLA THERAPEUTICS, INC. (PVLA)
- Reporting relationship
- CFO, Treasurer
- Issuer ticker
- PVLA
- Reported as of
- 12 Jun 2026
- Net transaction value
- $0
- SEC form
- 4
- Accepted by SEC
- 16 Jun 2026, 16:05:22 UTC
- Prior SEC filing
- 05 Jun 2026
- Source filing
- View source filing
- Reporting owner signature
- /s/ Kathleen A. McGowan, Attorney-in-Fact
Source evidence
Original filing metadata and source links for verification.
4 source fields
Reporting owner
1 detail
Key filing fact
Matthew E. Korenberg filed Form 4 for PALVELLA THERAPEUTICS, INC. (PVLA) on 16 Jun 2026.
Change
- Previous filing in this sequence was filed on 05 Jun 2026.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reporting Owners (1)
CIK 0001649903
Primary reporting owner
Korenberg Matthew E
- Relationship
- CFO, Treasurer
- Address
- C/O PALVELLA THERAPEUTICS, INC., 353 W. LANCASTER AVENUE, SUITE 200, WAYNE
- Signature
- /s/ Kathleen A. McGowan, Attorney-in-Fact
- Signature date
- 16 Jun 2026
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
PVLA
transaction
Common Stock
Options Exercise
- Transaction value
- Shares
- +1,000
- Change %
- Price
- $13.60*
- Shares after
- 1,000
- Date
- 12 Jun 2026
- Ownership
- Direct
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
PVLA
transaction
Derivative
Stock Option (Right to Buy)
Options Exercise
- Transaction value
- Shares
- -1,000
- Change %
- -0.6%
- Price
- $0.000000*
- Shares after
- 166,100
- Date
- 12 Jun 2026
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 1,000
- Exercise price
- $13.60
- Footnotes
- F1
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 1 footnote
Footnote F1
25% of the stock options will vest on October 16, 2025, and the remaining 75% will vest in equal monthly tranches over the following 36 months.